Genetic Engineering of <i>Lactococcus lactis</i> Co-producing Antigen and the Mucosal Adjuvant 3' 5'- cyclic di Adenosine Monophosphate (c-di-AMP) as a Design Strategy to Develop a Mucosal Vaccine Prototype.

Front Microbiol · 2018 · PMC6143824 · PMID 30258417

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significancep < 0.06so close (0.05 < p ≤ 0.1)

In addition, the cellular response noticed in LL3 was smaller than that registered in LL7, although it did not reach statistical significance ( p < 0.06).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.